31st Annual J.P. Morgan Healthcare Conference
Light the 'Fusilev' on Success; Spectrum Details Growth Plan
By Randy Osborne
Thursday, January 10, 2013
During a first-of-the-day session at the J.P. Morgan Healthcare Conference, Spectrum Pharmaceuticals Inc.'s chairman, president and CEO, Rajesh Shrotriya, took on squarely the "much-talked about" matter of boosting Fusilev sales.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.